Welcome to SGC

Open Lab Notebooks

Extreme Open Science Initiative: SGC scientists around the world are starting to post their lab notebook online in real time.

About

The SGC is a public-private partnership that supports the discovery of new medicines through open access research.

Reagents & Resources

Created, discovered and shared by the SGC without restriction on use: innovation for everyone.

People

A Global network of multi-talented and multi-cultural team of cross-disciplinary scientists: all committed to accelerate drug discovery.

Latest Structures

USP05: Human ubiquitin specific peptidase 5, second ZnF domain, in complex with inhibitor DAT180
USP05: Human ubiquitin specific peptidase 5, second ZnF domain, in complex with inhibitor DAT201
CARM1: Human coactivator associated arginine methyltransferase 1, methyltransferase domain, in complex with inhibitor (R)-SKI-72
LOC149281: Human Alpha N-terminal protein methyltransferase 1B (a.k.a NTM1B), methyltransferase domain, in complex with SPKRI peptide substrate
MBD1: Human methyl-CpG binding domain protein 1, MBD domain, in complex with methylated DNA
MBD3: Human methyl-CpG binding domain protein 3, MBD domain, in complex with methylated CpG DNA
CARM1: Human coactivator associated arginine methyltransferase 1, methyltransferase domain, in complex with inhibitor (S)-SKI-72
all structures

New Publications

The Combination of Human Urinary Kallidinogenase and Mild Hypothermia Protects Adult Rats Against Hypoxic-Ischemic Encephalopathy-Induced Injury by Promoting Angiogenesis and Regeneration.
Front Aging Neurosci
SGC-GAK-1: a chemical probe for cyclin G associated kinase (GAK)
Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling.
EMBO Journal
Zinc(II) binding on human wild-type ISCU and Met140 variants modulates NFS1 desulfurase activity.
Biochimie
LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity.
ACS Med Chem Lett
A TFEB nuclear export signal integrates amino acid supply and glucose availability.
Nature Communications
Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial.
EBioMedicine
full list

Chemical Probes

BI-9321 - for NSD3
18th July 2018
MRK-740 - for PRDM9
26th June 2018
SGC3027 - for PRMT7
22nd March 2018
SGC-GAK-1 - a chemical probe for GAK
27th February 2018
show all

News from SGC

Open Science Probe Project launched
Posted on 9th May 2018
Conference announcement: BMP Signalling in Cancer II
Posted on 16th March 2018
ALS Reproducible Antibody Platform: Open Science to enable consistent data and accelerate reliable discoveries in Amyotrophic Lateral Sclerosis
Posted on 7th March 2018
more news
 

Focus on...

Research Informatics at SGC
With the involvement of:

SGC Careers

Open vacancies : 3
SGC Oxford - Research Assistant - Genome Integrity
SGC Oxford - Postdoctoral Scientist - Membrane Protein Production Group 1
SGC Oxford - Postdoctoral Scientist – Integral Membrane Proteins Group 1
SGC Careers page
 
glqxz9283 sfy39587stf02 mnesdcuix8
sfy39587stf03